Published in ACS Med Chem Lett on January 25, 2015
Assessment of tryptophan uptake and kinetics using 1-(2-[18F]fluoroethyl)-L-tryptophan and α-[11C]-methyl-L-tryptophan PET imaging in mice implanted with patient-derived brain tumor xenografts. J Nucl Med (2016) 0.76
Imaging cerebral tryptophan metabolism in brain tumor-associated depression. EJNMMI Res (2015) 0.75
Improved Radiosynthesis and Biological Evaluations of L- and D-1-[(18)F]Fluoroethyl-Tryptophan for PET Imaging of IDO-Mediated Kynurenine Pathway of Tryptophan Metabolism. Mol Imaging Biol (2016) 0.75
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med (2003) 7.86
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood (2004) 6.02
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today (1999) 3.74
Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol (2012) 2.37
Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov (2012) 2.29
IDO and tolerance to tumors. Trends Mol Med (2004) 2.03
Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Res (2012) 1.98
Indoleamine 2,3-dioxygenase in immune suppression and cancer. Curr Cancer Drug Targets (2007) 1.86
Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. Biochem Biophys Res Commun (2005) 1.67
IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival. Clin Cancer Res (2012) 1.55
Biochemical and autoradiographic measurements of brain serotonin synthesis rate in the freely moving rat: a reexamination of the alpha-methyl-L-tryptophan method. J Neurochem (1999) 1.52
The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.44
Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses (2003) 1.37
IDO expression in the brain: a double-edged sword. J Mol Med (Berl) (2007) 1.30
Evidence for a ferryl intermediate in a heme-based dioxygenase. Proc Natl Acad Sci U S A (2009) 1.13
Reassessment of the reaction mechanism in the heme dioxygenases. J Am Chem Soc (2009) 1.11
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators. J Med Chem (2011) 1.10
A kinetic, spectroscopic, and redox study of human tryptophan 2,3-dioxygenase. Biochemistry (2008) 1.09
Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease. Amino Acids (2008) 1.06
Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase. J Am Chem Soc (2009) 1.03
The kynurenine pathway in brain tumor pathogenesis. Cancer Res (2012) 1.03
Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 - 2012). Expert Opin Ther Pat (2013) 1.02
Functional characterization of the cyclomarin/cyclomarazine prenyltransferase CymD directs the biosynthesis of unnatural cyclic peptides. J Nat Prod (2010) 0.99
Nitration and inactivation of IDO by peroxynitrite. J Immunol (2006) 0.99
Differential kinetics of α-[¹¹C]methyl-L-tryptophan on PET in low-grade brain tumors. J Neurooncol (2010) 0.97
Reusable polymer-supported catalyst for the [3+2] Huisgen cycloaddition in automation protocols. Org Lett (2006) 0.96
Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies. Nucl Med Biol (2012) 0.91
Complete reaction mechanism of indoleamine 2,3-dioxygenase as revealed by QM/MM simulations. J Phys Chem B (2012) 0.90
The mechanism of formation of N-formylkynurenine by heme dioxygenases. J Am Chem Soc (2011) 0.89
In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1. Cancer Biol Ther (2013) 0.85
Radiosynthesis of 1-[18F]fluoroethyl-L-tryptophan as a novel potential amino acid PET tracer. Appl Radiat Isot (2011) 0.82
Brain kinetics of 11 C-labelled L-tryptophan and 5-hydroxy-L-tryptophan in the rhesus monkey. A study using positron emission tomography. J Neural Transm Gen Sect (1992) 0.81
DL-[Carboxyl-11C]tryptophan, a potential agent for pancreatic imaging; production and preclinical investigations. J Nucl Med (1979) 0.80
5-Hydroxy-L-[beta-11C]tryptophan versus alpha-[11C]methyl-L-tryptophan for positron emission tomography imaging of serotonin synthesis capacity in the rhesus monkey brain. J Cereb Blood Flow Metab (2006) 0.80
Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors. Eur J Med Chem (2011) 0.80
Site-specific incorporation of diamondoids on DNA using click chemistry. Chem Commun (Camb) (2012) 0.79